Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASnoid interaction with the cannabinoid receptors, the anandamide transporterand fatty acid amidohydrolase. Chemistry and Physics of Lipids, 108:15–35.Rehm J y colab. (2001) Feasibility, safety, and efficacy of injectable heroin prescriptionfor refractory opioid addicts: a follow-up study. Lancet,358:1417–1420.Riegel AC, French ED (1999) An electrophysiological analysis of rat ventraltegmental dopamine neuronal activity during acute toluene exposure.Pharmacology and Toxicology, 85:37–43.Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding atdopamine, norepinephrine and serotonin transporters: a structure–activitystudy. Life Sciences, 46:635–645.Robinson TE, Becker JB (1986) Enduring changes in brain and behavior producedby chronic amphetamine administration: a review and evaluation of animalmodels of amphetamine psychosis. Brain Research Reviews, 11:157–198.Rocha BA y colab. (1998) Cocaine self-administration in dopamine-transporterknockout mice. Nature Neuroscience, 1:132–137.Rodríguez de Fonseca F y colab. (1997) Activation of corticotropin-releasing factorin the limbic system during cannabinoid withdrawal. Science,276:2050–2054.Rogers RD, Robbins TW (2001) Investigating the neurocognitive deficits associatedwith chronic drug misuse. Current Opinion in Neurobiology, 11:250–257.Rose JE, Behm FM, Levin ED (1993) Role of nicotine dose and sensory cues in theregulation of smoke intake. Pharmacology, Biochemistry and Behavior, 44:891–900.Rosecrans JA, Karan LD (1993) Neurobehavioral mechanisms of nicotineaction: role in the initiation and maintenance of tobacco dependence. Journal ofSubstance Abuse Treatment, 10:161–170.Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agentson humans, animals, and drug-seeking behavior, and its implications for medicationdevelopment: focus on GBR12909. Molecular Neurobiology, 11:1–19.Royal College of Physicians (2000) Nicotine addiction in Britain: a report of theTobacco Advisory Group of the Royal College of Physicians. Londres, RelColegio de Médicos.Russell MAH (1987) Nicotine intake and its regulation by smokers. En: MartinWR y colab., eds. Advances in behavioral biology. Vol 31. Tobacco smoking andnicotine. Nueva York, NY, EE.UU. Plenum Press:25–31.Samson HH, Chappell A (2001) Muscimol injected into the medial prefrontalcortex of the rat alters ethanol self-administration. Physiology and Behavior,74:581–587.Scallet AC (1991) Neurotoxicology of cannabis and THC: a review of chronicexposure studies in animals. Pharmacology, Biochemistry and Behavior,40:671–676.Schilstrom B y colab. (1998) Nicotine- and food-induced dopamine release inthe nucleus accumbens of the rat: putative role of alpha-7 nicotinic receptors inthe ventral tegmental area. Neuroscience, 85:1005–1009.119
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASShankaran M, Gudelsky GA (1999) A neurotoxic regimen of MDMA suppressesbehavioral, thermal and neurochemical responses to subsequent MDMAadministration. Psychopharmacology, 147:66–72.Shaper AG (1996) Walking on the moon. Lancet, 347:207–208.Shiffman S, Mason KM, Henningfield JE (1998) Tobacco dependence treatments:review and prospectus. Annual Review of Public Health, 19:335–358.Shulgin AT (1986) The background and chemistry of MDMA. Journal ofPsychoactive Drugs, 18:291–304.Solowij N, Michie PT, Fox AM (1995) Differential impairments of selective attentiondue to frequency and duration of cannabis use. Biological Psychiatry, 37:731–739.Sora I ¡Error! Marcador no definido.y colab¡Error! Marcador no definido..(2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonintransporter knockouts eliminate cocaine place preference. Proceedings ofthe National Academy of Science of the United States of America, 98:5300–5305.Soria R y colab. (1996) Subjective and cardiovascular effects of intravenous nicotinein smokers and non-smokers. Psychopharmacology (Berlin), 128:221–226.Spyraki C, Kazandjian A, Varonos D (1985) Diazepam-induced place preferenceconditioning: appetitive and antiaversive properties. Psychopharmacology(Berlin), 87:225–232.Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P (2001) Treatment foramphetamine dependence and abuse. Cochrane Database of Systematic Reviews,4:CD003022.Stengard K, Hoglund G, Ungerstedt U (1994) Extracellular dopamine levels withinthe striatum increase during inhalation exposure to toluene: a microdialysis studyin awake, freely- moving rats. Toxicology Letters, 71:245–255.Streeton C, Whelan G (2001) Naltrexone: a relapse prevention maintenancetreatment of alcohol dependence – a meta-analysis of randomized controlled trials.Alcohol and Alcoholism, 36:544–552.Sugiura T y colab. (1995) 2-Arachidonoylglycerol: a possible endogenouscannabinoid receptor ligand in the brain. Biochemical and Biophysical ResearchCommunications, 215:89–97.Sutherland G (2002) Current approaches to the management of smoking cessation.Drugs, 62(Suppl. 2):S53–S61.Swedberg MDB, Henningfield JE, Goldberg SR (1990) Nicotine dependency:animal studies. In: Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine psychopharmacology:molecular, cellular and behavioural aspects. Nueva York, EE.UU.Oxford University Press:38–76.Szostak C, Finlay JM, Fibiger HC (1987) Intravenous self-administration of the shortactingbenzodiazepine midazolam in the rat. Neuropharmacology, 26:1673–1676.Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activationof mesolimbic dopamine transmission by a common 1-opioid receptor mechanism.Science, 276:2048–2050.Taylor P (1996) Agents acting at the neuromuscular junction and autonomicganglia. En: Hardman JG y colab., eds. Goodman and Gilman's pharmacologicalbasis of therapeutics, 9a. ed. Nueva York, NY, EE.UU. McGraw-Hill:177–197.120
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 146 and 147: Capítulo 5Bases Genéticas de lasF
Page 148 and 149: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191:
Capítulo 6Trastornos ConcurrentesI
Page 192 and 193:
6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195:
6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197:
6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199:
6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201:
6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203:
6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205:
6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207:
6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209:
6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211:
6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213:
6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215:
6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217:
6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219:
6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221:
6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223:
6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225:
6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227:
6. TRASTORNOS CONCURRENTESSevy S y
Page 228:
6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?